New teaching model helps jaundice patients prepare for home care
NCT ID NCT07525804
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested whether a structured 'flipped-discharge' education program helps adults with jaundice caused by cancer feel more ready to go home after a drainage procedure. 80 participants were randomly assigned to either the new education model or standard discharge instructions. The program included hands-on catheter care training, personalized discharge planning, and weekly phone check-ins for the first month after leaving the hospital.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Flipped-Discharge Education Model
- What this could lead to
- If it works, this could improve how well patients care for their drainage tube at home and feel more prepared to leave the hospital.
- What could go wrong
- This is a small, single-center study with only 80 participants, so results may not apply to all patients. The intervention is educational, not a drug, so benefits are limited to better self-care and quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
80 people
The number who actually took part.
- Started
-
Dec 2023
- Finished
-
Jun 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18 years or older * Diagnosed with malignant obstructive jaundice * Undergoing percutaneous transhepatic cholangiodrainage (PTCD) * Clear indication for PTCD, such as unresectable biliary obstruction * Preserved consciousness and ability to communicate * Provided written informed consent Exclusion Criteria: * Psychiatric disorders * Active severe infection * Hematologic disease * Language barriers * Anticipated loss to follow-up * Disease progression, death during the study period, or voluntary withdrawal
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Malignant obstructive jaundice are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Foshan First People's Hospital
Foshan, Guangdong, 528000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.